补充生物传感器识别了在补充介导的血溶性尿素综合征中的经典途径刺激
bioRxiv : the preprint server for biology
|June 10, 2024
概括
补充介导的血溶性尿素综合征 (CM-HUS) 诊断得到了新的基于细胞的生物传感器的改进. 这些工具可以识别IgM驱动的刺激,解释CM-HUS缺少替代途径变异的病例.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 生物技术是生物技术.
背景情况:
- 补充介导的血溶性尿素综合征 (CM-HUS) 是一种严重的血栓性微血管病变.
- 诊断通常依赖于识别影响补体调节的遗传变异或抗体.
- 现有的诊断方法可能无法完全解释所有CM-HUS病例.
研究的目的:
- 开发和验证新的基于细胞的补充生物传感器,用于CM-HUS诊断.
- 研究补充通路的作用,特别是IgM驱动的刺激,在CM-HUS病变发生过程中.
- 评估这些生物传感器在监测补充抑制剂治疗中的有用性.
主要方法:
- 设计了缺乏特定补充调节蛋白 (CD55,CD59,CD46) 的HEK293细胞,以创建生物发光生物传感器.
- 使用修改后的Ham (mHam) 测试框架进行ex vivo补充分析.
- 采用特定的补充通路抑制剂来剖析通路激活.
主要成果:
- 开发的生物传感器有效地诊断CM-HUS并监测补体阻塞.
- 在CM-HUS患者中确定了IgM驱动的古典通路刺激,即使在缓解期间.
- 这一发现可能解释了~50%的CM-HUS没有替代途径变异的病例.
结论:
- 基于细胞的补体生物传感器为CM-HUS.US提供了一个敏感的诊断工具.
- 一个CM-HUS的子集可能是由于IgM免疫耐受性的分解而产生的.
- 这些生物传感器可以帮助诊断CM-HUS,并指导补充抑制剂治疗.
相关概念视频
Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
Enzyme-Linked Immunosorbent Assay
12.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...
12.9K
Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K


